| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 13.964 | 10.785 | 8.383 | 25.344 | 6.888 | 9.351 | 12.443 | 13.607 | 14.422 |
| Total Income - EUR | 0 | 13.964 | 10.786 | 8.385 | 25.346 | 6.888 | 9.351 | 12.443 | 13.607 | 14.422 |
| Total Expenses - EUR | 0 | 4.134 | 2.824 | 2.282 | 1.980 | 4.206 | 11.203 | 14.514 | 21.755 | 23.854 |
| Gross Profit/Loss - EUR | 0 | 9.830 | 7.961 | 6.103 | 23.365 | 2.682 | -1.852 | -2.071 | -8.148 | -9.431 |
| Net Profit/Loss - EUR | 0 | 9.408 | 7.636 | 5.852 | 22.605 | 2.483 | -2.108 | -2.437 | -8.148 | -9.431 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Imed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 83 | 0 | 715 | 378 | 370 | 363 | 16.641 | 11.395 | 6.078 | 791 |
| Current Assets | 45 | 9.533 | 7.665 | 6.781 | 23.450 | 25.489 | 6.679 | 9.427 | 6.509 | 2.835 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 1.661 | 460 | 0 | 632 | 620 | 0 | 0 | 283 | 358 |
| Cash | 45 | 7.872 | 7.205 | 6.781 | 22.818 | 24.869 | 6.679 | 9.427 | 6.226 | 2.477 |
| Shareholders Funds | -20 | 523 | 591 | 1.166 | 23.748 | 25.780 | 23.101 | 20.736 | 12.525 | 3.023 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 148 | 9.010 | 7.788 | 5.993 | 72 | 73 | 219 | 86 | 62 | 603 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Imed Srl